Trillium therapeutics board of directors
WebJun 30, 2024 · Dr. Mackey has more than 30 years of operating experience in the pharmaceutical and biotechnology sectors. From May 2001 to December 2010, Dr. Mackey served as SVP, Global R&D, and Director, of Pfizer’s La Jolla Laboratories, one of Pfizer’s primary pharmaceutical research and development sites. During her tenure, Pfizer La Jolla … WebNov 12, 2024 · “We are delighted to welcome Mr. Pucci to the board of directors” said Robert ... James Parsons Chief Financial Officer Trillium Therapeutics Inc. 416-595-0627 x232 james@ ...
Trillium therapeutics board of directors
Did you know?
WebApr 13, 2024 · BOSTON , April 13, 2024 /PRNewswire/ -- Today, Trillium Capital LLC announced Its proposal for the Board of Directors of Getty Images Holding, Inc. (NASDAQ: GETY) ("Getty" or the "Company") to hire a national investment banking firm to seek out strategic alternatives. The principles of Trillium Capital LLC own hundreds of thousand … WebFeb 7, 2024 · Paul Walker of New Enterprise Associates is appointed to the Board of Directors; CAMBRIDGE, Mass., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Trillium Therapeutics …
WebApr 14, 2024 · A. Teilen. Drucken. BOSTON, April 14, 2024 /PRNewswire/ -- Today, Trillium Capital LLC announced that it has requested that its Managing Partner, Scott Murray, join … WebOct 11, 2024 · Trillium Therapeutics Inc. , a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, announced today that Dr. Helen Tayton-Martin has been appointed to its ...
WebSep 18, 2024 · Industry Veteran Brings Deep Biologics Manufacturing Experience to Trillium BoardCAMBRIDGE, Mass., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company ... WebOct 11, 2024 · Trillium Therapeutics Inc. , a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, announced today that Dr. …
WebAlong with hospitalization for acute coronavirus disease 2024 (COVID-19), multisystem inflammatory syndrome in children (MIS-C) has emerged as a serious yet infrequent complication of paediatric severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Though MIS-C was first described in the United Kingdom in April 2024, to date ...
WebApr 28, 2024 · CAMBRIDGE, Mass., April 28, 2024 (GLOBE NEWSWIRE) — Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today provided a data update, announced Phase 1b/2 program priorities across seven hematologic and solid tumor … thickening of the bladder wall cancerWebNov 5, 2008 · TORONTO, Nov. 5 /PRNewswire/ - Trillium Therapeutics Inc., a privately held biopharmaceutical company, announced today that industry veterans Dr. Michael Berendt and Dr. John Dietrich have joined its Board as independent directors. Trillium Chairman Dr. Michael Moore commented: "It is a great pleasure to welcome these two experienced … s.a.health deptWebApr 13, 2024 · BOSTON, April 13, 2024 /PRNewswire/ -- Today, Trillium Capital LLC announced Its proposal for the Board of Directors of Getty Images Holding, Inc. (NASDAQ: GETY) ("Getty" or the "Company") to hire a national investment banking firm to seek out strategic alternatives. The principles of Trillium Capital LLC own hundreds of thousand … sa health directorWeb16 hours ago · Earlier this week, Trillium sent the Getty board a proposal and issued an open letter, saying a sale to either private equity or strategic players could boost the company's … thickening of the bronchial wallsWebTrillium Therapeutics Appoints Paolo Pucci to Its Board of Directors Industry Veteran Brings Deep Executive and Commercial Experience to Trillium Board CAMBRIDGE, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative … thickening of the blood vesselsWebOct 21, 2024 · Myers is an independent director on the board of directors of Selecta Biosciences, Trillium Therapeutics, Inc. and Harpoon Therapeutics, Inc. Mr. Myers holds a B.A. in Biology from Northwestern ... thickening of the breasthttp://ir.macrogenics.com/corporate-governance/board-of-directors thickening of the central cord plantar fascia